文献速递类风湿关节炎

移动应用程序监测类风湿关节炎患者报告结局的随机对照试验结果

Outcomes of a Mobile App to Monitor Patient-Reported Outcomes in Rheumatoid Arthritis: A Randomized Controlled Trial.
PubMed 文献 · Arthritis Rheumatol · 2021-06-18

该6个月随机对照试验纳入191例类风湿关节炎患者,比较护理协调联合应用程序(干预组)与单纯护理协调(对照组)对患者满意度和疾病活动度的影响。结果显示两组6个月时TSQM、PEPPI及CDAI中位数均无统计学显著差异,但患者和医生对应用程序体验积极。

要点

  • 应用程序联合护理协调未显著改善患者满意度或疾病活动度。
  • 6个月时两组TSQM和PEPPI中位数均为83.3和50,CDAI中位数为8 vs 10。
  • 90%完成退出调查的干预组患者推荐应用程序可能性≥7/10。

核心结论

  • 与单纯护理协调相比,用于收集RA症状ePRO数据的移动应用程序未显著改善患者满意度或疾病活动度。
  • 患者和医生均报告了对应用程序的积极体验。

研究设计与样本

  • 6个月随机对照试验,纳入191例类风湿关节炎患者,比较护理协调联合应用程序(干预组)与单纯护理协调(对照组)。
  • 干预组参与者被提示每日使用ePROs提供信息;两组均在6周和18周由护理协调员联系评估 flare。

主要发现

  • 6个月时TSQM中位数两组均为83.3,PEPPI中位数两组均为50。
  • 6个月时CDAI中位数干预组为8,对照组为10。
  • 6个月时TSQM、PEPPI或CDAI中位数均未检测到统计学显著的组间差异。
  • 完成退出调查的67例干预组参与者中,90%将推荐应用程序的可能性评为≥7/10。
  • 完成退出调查的11名医生中,73%同意/强烈同意希望继续向患者提供该应用程序。

临床怎么用

  • 移动应用程序监测ePROs未能显著改善RA患者满意度或疾病活动度,但患者和医生体验积极,可作为护理协调的辅助工具。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the effects of a smartphone application (app) to monitor longitudinal electronic patient-reported outcomes (ePROs) on patient satisfaction and disease activity in patients with rheumatoid arthritis (RA). METHODS: We conducted a 6-month randomized controlled trial of care coordination along with an app (intervention) versus care coordination alone (control) in 191 RA patients. Participants in the intervention group were prompted to provide information daily using ePROs. In both the intervention and control groups, a care coordinator contacted participants at 6 and 18 weeks to assess for flares. The main outcome measures were the global satisfaction score from the Treatment Satisfaction Questionnaire for Medication (TSQM), the score from the Perceived Efficacy in Patient-Physician Interactions (PEPPI) Questionnaire, and the Clinical Disease Activity Index (CDAI) score. RESULTS: Groups were similar at baseline. The median TSQM score at 6 months was 83.3 in both groups, and the median PEPPI score at 6 months was 50 in both groups. The median CDAI score at 6 months was 8 in the intervention group versus 10 in the control group. No statistically significant group differences in the medians of TSQM, PEPPI, or CDAI scores at 6 months were detected. Of the 67 intervention participants who completed the exit survey, 90% rated their likelihood of recommending the app as ≥7 of 10. Of the 11 physicians who completed the exit survey, 73% agreed/strongly agreed that they wanted to continue offering the app to patients. CONCLUSION: A mobile app designed to collect ePRO data on RA symptoms did not significantly improve patient satisfaction or disease activity compared to care coordination alone. However, both patients and physicians reported positive experiences with the app.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Lee YC, Lu F, Colls J, et al. Outcomes of a Mobile App to Monitor Patient-Reported Outcomes in Rheumatoid Arthritis: A Randomized Controlled Trial. Arthritis Rheumatol. 2021. PMID: 33559338. doi:10.1002/art.41686

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。